AI in Pharma Due Diligence: Leveraging for Licensing and M&A
Introduction Due diligence (DD) in pharmaceutical licensing and M&A has always been a resource-intensive exercise. Thousands of documents - clinical data packages, IP portfolios, regulatory submissions, commercial contracts, manufacturing records,…
